Nova Leap Health (CVE:NLH) Lifted to “Strong-Buy” at Ventum Cap Mkts

Ventum Cap Mkts upgraded shares of Nova Leap Health (CVE:NLH) to a strong-buy rating in a report issued on Friday, Zacks.com reports.

Nova Leap Health Trading Down 13.6 %

Shares of CVE NLH opened at C$0.29 on Friday. The company has a debt-to-equity ratio of 6.84, a current ratio of 1.78 and a quick ratio of 1.13. The firm has a 50-day moving average of C$0.30 and a 200 day moving average of C$0.27. Nova Leap Health has a 1 year low of C$0.15 and a 1 year high of C$0.38. The stock has a market cap of C$24.57 million, a P/E ratio of -14.25 and a beta of 1.54.

Nova Leap Health (CVE:NLH) last announced its earnings results on Thursday, May 9th. The company reported C$0.01 earnings per share for the quarter. The business had revenue of C$8.67 million during the quarter, compared to analyst estimates of C$8.78 million. Nova Leap Health had a negative net margin of 1.09% and a negative return on equity of 1.55%. As a group, sell-side analysts expect that Nova Leap Health will post 0.0137948 EPS for the current fiscal year.

Insider Transactions at Nova Leap Health

In other news, Director R. Wayne Myles acquired 140,000 shares of the business’s stock in a transaction on Friday, May 17th. The shares were acquired at an average price of C$0.30 per share, for a total transaction of C$41,328.00. Insiders have acquired a total of 239,000 shares of company stock worth $71,371 in the last three months. Insiders own 40.86% of the company’s stock.

Nova Leap Health Company Profile

Nova Leap Health Corp., together with its subsidiaries, provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders.